|
MRPL44 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.272400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.174800E-01 |
| Normal-vs-Stage2 |
6.475600E-01 |
| Normal-vs-Stage3 |
9.512600E-01 |
| Normal-vs-Stage4 |
1.200610E-01 |
| Stage1-vs-Stage2 |
2.936400E-01 |
| Stage1-vs-Stage3 |
4.828000E-01 |
| Stage1-vs-Stage4 |
4.330400E-01 |
| Stage2-vs-Stage3 |
6.952400E-01 |
| Stage2-vs-Stage4 |
2.145800E-01 |
| Stage3-vs-Stage4 |
1.894960E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.318600E-01 |
| Normal-vs-AfricanAmerican |
4.059600E-01 |
| Normal-vs-Asian |
8.473800E-01 |
| Caucasian-vs-AfricanAmerican |
7.873600E-01 |
| Caucasian-vs-Asian |
9.262600E-01 |
| AfricanAmerican-vs-Asian |
9.999600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.598200E-01 |
| Normal-vs-Female |
5.366000E-01 |
| Male-vs-Female |
9.947400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.082800E-01 |
| Normal-vs-Extreme_Weight |
6.464400E-02 |
| Normal-vs-Obese |
3.785400E-01 |
| Normal-vs-Extreme_Obese |
3.351600E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.685200E-01 |
| Normal_Weight-vs-Obese |
6.306200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.962500E-02 |
| Extreme_Weight-vs-Obese |
5.168600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.618210E-01 |
| Obese-vs-Extreme_Obese |
1.023380E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.799600E-01 |
| Normal-vs-Age(41-60Yrs) |
6.469800E-01 |
| Normal-vs-Age(61-80Yrs) |
2.785200E-01 |
| Normal-vs-Age(81-100Yrs) |
9.326600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.464800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.615400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.954400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.107200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.996400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.357000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.481600E-01 |
| Normal-VS-Type2 PRCC |
6.426000E-01 |
| Normal-VS-KIRP CIMP |
2.798500E-02 |
| Normal-VS-Unclassified PRCC |
9.310000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.286400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.082800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.230800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.282100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
8.153400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.418620E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.078600E-01 |
| Normal-vs-N1 |
5.105000E-01 |
| Normal-vs-N2 |
6.010900E-04 |
| N0-vs-N1 |
7.064800E-01 |
| N0-vs-N2 |
2.122600E-01 |
| N1-vs-N2 |
2.460400E-01 |
|
|
